Nina A. Bickell, MD, MPH; Mark R. Chassin, MD, MPP, MPH
Acknowledgments: The authors thank the members of the Mount Sinai-New York University Health System Early-Stage Breast Cancer Treatment Quality Improvement Steering Committee (Drs. Miguel Sanchez, Lewis Attas, David Dubin, Samuel Kopel, Morton Davidson, Angelo Cammarata, Alan Sickles, and Richard Hirshman and Ms. Annette Angelone); the tumor registrars of Cabrini, Englewood, and Maimonides hospitals; and all the participating physicians.
Grant Support: By the United Hospital Fund (961046B) and the Department of Health Policy of the Mount Sinai School of Medicine.
Requests for Single Reprints: Nina A. Bickell, MD, MPH, Mount Sinai School of Medicine, Department of Health Policy, Box 1077, One Gustave L. Levy Place, New York, NY 10029.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Bickell and Chassin: Mount Sinai School of Medicine, Department of Health Policy, Box 1077, One Gustave L. Levy Place, New York, NY 10029.
Author Contributions: Conception and design: N.A. Bickell, M.R. Chassin.
Analysis and interpretation of the data: N.A. Bickell, M.R. Chassin.
Drafting of the article: N.A. Bickell.
Critical revision of the article for important intellectual content: N.A. Bickell, M.R. Chassin.
Final approval of the article: N.A. Bickell, M.R. Chassin.
Provision of study materials or patients: N.A. Bickell.
Statistical expertise: N.A. Bickell.
Obtaining of funding: N.A. Bickell, M.R. Chassin.
Administrative, technical, or logistic support: N.A. Bickell, M.R. Chassin.
Collection and assembly of data: N.A. Bickell.
Hospital tumor registries, which provide data that inform health services research and cancer control policies, may be a source of information about quality of cancer care. However, the accuracy of data from such registries is unknown.
To determine the accuracy of tumor registry data by comparing it with data collected from numerous sources for a breast cancer quality improvement project.
Retrospective cohort study.
Three teaching hospitals with tumor registries in the New York metropolitan area that had participated in the quality improvement project.
All women with newly diagnosed primary breast cancer (stage I or stage II) who were surgically treated at the study hospitals between 1 November 1994 and 31 August 1996.
Sensitivity and specificity were calculated, and data from the quality improvement project were used as the gold standard.
The tumor registries and the quality improvement project had similar information on tumor stage and surgery type. Sensitivity ranged from 0.91 to 0.96, and specificity ranged from 0.93 to 0.97. When both sources were used to calculate quality measures, the overall rate of radiation therapy after breast-conserving surgery was 80% in the quality improvement project and 48% in the tumor registries (sensitivity, 0.58; specificity, 0.94). For receipt of adjuvant systemic treatment, the rate was 78% in the quality improvement project and 22% in the tumor registries (sensitivity, 0.27; specificity, 0.97).
Data from tumor registries provide accurate measures for hospital-based surgical treatments but not for outpatient treatments. Unverified tumor registry data should not be used to measure quality of care.
Learn more about subscription options.
Register Now for a free account.
Bickell NA, Chassin MR. Determining the Quality of Breast Cancer Care: Do Tumor Registries Measure Up?. Ann Intern Med. 2000;132:705–710. doi: 10.7326/0003-4819-132-9-200005020-00004
Download citation file:
Published: Ann Intern Med. 2000;132(9):705-710.
Breast Cancer, Hematology/Oncology, Hospital Medicine.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only